{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "REGULAR", "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683834683, "regularMarketDayHigh": 2.25, "regularMarketDayRange": "2.25 - 2.25", "regularMarketDayLow": 2.25, "regularMarketVolume": 119, "regularMarketPreviousClose": 2.12, "bid": 2.08, "ask": 2.49, "bidSize": 8, "askSize": 18, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 2.26, "averageDailyVolume3Month": 3430, "averageDailyVolume10Day": 2250, "fiftyTwoWeekLowChange": 0.3499999, "fiftyTwoWeekLowChangePercent": 0.19774006, "fiftyTwoWeekRange": "1.77 - 7.0", "fiftyTwoWeekHighChange": -4.88, "fiftyTwoWeekHighChangePercent": -0.6971429, "fiftyTwoWeekLow": 1.77, "fiftyTwoWeekHigh": 7.0, "earningsTimestamp": 1683806400, "earningsTimestampStart": 1683806400, "earningsTimestampEnd": 1683806400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.44, "epsForward": -0.53, "epsCurrentYear": -0.53, "priceEpsCurrentYear": -4.0, "sharesOutstanding": 25633200, "bookValue": 0.645, "fiftyDayAverage": 2.71774, "fiftyDayAverageChange": -0.5977402, "fiftyDayAverageChangePercent": -0.21994016, "twoHundredDayAverage": 2.889765, "twoHundredDayAverageChange": -0.76976514, "twoHundredDayAverageChangePercent": -0.26637638, "marketCap": 54342380, "forwardPE": -4.0, "priceToBook": 3.2868216, "messageBoardId": "finmb_673614867", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 2.12, "exchange": "NCM", "regularMarketChangePercent": 0.0, "shortName": "Anebulo Pharmaceuticals, Inc.", "longName": "Anebulo Pharmaceuticals, Inc.", "firstTradeDateMilliseconds": 1620394200000, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-07", "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Anebulo Pharmaceuticals", "symbol": "ANEB"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1415 Ranch Road 620 South", "address2": "Suite 201", "city": "Lakeway", "state": "TX", "zip": "78734", "country": "United States", "phone": "512-598-0931", "website": "https://www.anebulo.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joseph F. Lawler M.D., Ph.D.", "age": 50, "title": "Founder & Chairman", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 11000, "fmt": "11k", "longFmt": "11,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon J. Allen B.Sc., M.B.A., MBA", "age": 54, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 450000, "fmt": "450k", "longFmt": "450,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kenneth C. Cundy Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 345526, "fmt": "345.53k", "longFmt": "345,526"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 33411, "fmt": "33.41k", "longFmt": "33,411"}}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 56, "title": "Acting Chief Financial Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott L. Anderson", "title": "Head of Investor Relations & Public Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}